4SC AG RPE

RPE компаний в Health Care сектор на XETRA по сравнению с 4SC AG

Что делает 4SC AG?

4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.

Компании с rpe похож на 4SC AG

• Jumia Technologies AG имеет RPE из $53.468k
• LSL Property Services Plc имеет RPE из £53.511k
• Neovasc имеет RPE из $53.549k
• Stanley Furniture имеет RPE из $53.560k
• VR Education Plc имеет RPE из €53.618k
• City of London plc имеет RPE из £53.618k
• 4SC AG имеет RPE из €53.619k
• Greenpro Capital имеет RPE из $53.672k
• Xinyang Maojian имеет RPE из HKD$53.752k
• I.Céram SA имеет RPE из €53.842k
• Génomic Vision SA имеет RPE из €53.852k
• Profound Medical имеет RPE из $53.973k
• Nikola имеет RPE из $54.018k